Allogeneic Bone Marrow‐Derived Mesenchymal Stromal Cells Expanded In Vitro for Treatment of Aplastic Anemia: A Multicenter Phase II Trial

We conducted a phase II, noncomparative, multicenter study to assess the efficacy and safety of allogeneic bone marrow‐derived mesenchymal stromal cells (BM‐MSCs) expanded in vitro for patients with aplastic anemia (AA) refractory to immunosuppressive therapy. Seventy‐four patients from seven center...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Yan, Xiao, Hao‐Wen, Zhang, Hang, Liu, Zeng‐Hui, Li, Li, Gao, Yang, Li, Hong‐Bo, Jiang, Zu‐Jun, Tan, Huo, Lin, Jing‐Ren, Du, Xin, Weng, Jian‐Yu, Nie, Da‐Nian, Lin, Dong‐Jun, Zhang, Xiang‐Zhong, Liu, Qi‐Fa, Xu, Duo‐Rong, Chen, Hai‐Jia, Ge, Xiao‐Hu, Wang, Xiao‐Yan, Xiao, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Human Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689769/
https://www.ncbi.nlm.nih.gov/pubmed/28504860
http://dx.doi.org/10.1002/sctm.16-0227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689769/
https://www.ncbi.nlm.nih.gov/pubmed/28504860
http://dx.doi.org/10.1002/sctm.16-0227

Ejemplares similares